Clinical Trial Update: Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating decitabine-primed tandem CD19/CD20 CAR T cells in relapsed and refractory B-cell non-Hodgkin lymphoma is currently active-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Decitabine-primed Tandem CD19/CD20 CAR T Cells

Snippet

Sponsor: Han weidong | Conditions: Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma, Decitabine-primed Tandem CD19/CD20 CAR T Cells | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING